Analgesics - Ukraine | Statista Market Forecast

In Ukraine, the revenue generated in the Analgesics market in 2024 amounts to US$462.20m.
It is projected to experience an annual growth rate of 5.34% (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue in this market, with a total of US$7.24bn in 2024.
Taking into account the total population figures, the per person revenue in Ukraine for 2024 is US$12.18.
The demand for analgesics in the OTC Pharmaceuticals market in Ukraine is driven by a high prevalence of chronic pain conditions.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Ukraine is experiencing significant growth and development.

Customer preferences: Customers in Ukraine have a strong preference for analgesics due to the increasing prevalence of chronic pain conditions and the rising awareness about the importance of pain management. The aging population in Ukraine is also contributing to the growing demand for analgesics, as elderly individuals are more likely to experience pain and require medication for relief. Additionally, customers in Ukraine are becoming more health-conscious and are seeking out analgesics that are safe, effective, and have minimal side effects.

Trends in the market: One major trend in the Analgesics market in Ukraine is the shift towards non-opioid analgesics. This trend is driven by the increasing concern over the opioid crisis and the associated risks of addiction and overdose. As a result, customers are turning to non-opioid options such as nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen for pain relief. This trend is expected to continue as healthcare professionals and regulatory authorities in Ukraine promote the responsible use of analgesics and educate the public about the risks of opioid medications.Another trend in the market is the growing popularity of topical analgesics. These products are applied directly to the skin and provide localized pain relief. Topical analgesics are preferred by customers in Ukraine due to their convenience, ease of use, and targeted action. They are especially popular for relieving muscle and joint pain, which is common among individuals who engage in physical labor or sports activities. The availability of a wide range of topical analgesic products in the market is also contributing to their increasing popularity.

Local special circumstances: One of the special circumstances in the Analgesics market in Ukraine is the high prevalence of counterfeit and substandard medications. This poses a significant challenge for both customers and market players. Customers may unknowingly purchase counterfeit or substandard analgesics, which can have serious health consequences. Market players, on the other hand, need to invest in stringent quality control measures to ensure the authenticity and safety of their products. Regulatory authorities in Ukraine are taking steps to address this issue by implementing stricter regulations and increasing surveillance of the market.

Underlying macroeconomic factors: The growth of the Analgesics market in Ukraine is also influenced by underlying macroeconomic factors. The improving economic conditions in the country have led to an increase in disposable income, allowing customers to spend more on healthcare products, including analgesics. Furthermore, the expansion of the healthcare sector and the increasing availability of healthcare services in Ukraine have contributed to the growth of the analgesics market. As healthcare facilities become more accessible to the population, the demand for analgesics is expected to rise.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.